Scott D. Ferguson - 30 Nov 2021 Form 4 Insider Report for Elanco Animal Health Inc (ELAN)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
02 Dec 2021, 17:25:58 UTC
Prior SEC filing
02 Sep 2021
Next SEC filing
03 May 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Michael D. Adamski, as Attorney-in-Fact

Key filing fact

Scott D. Ferguson filed Form 4 for Elanco Animal Health Inc (ELAN) on 02 Dec 2021.

Key facts

  • This page summarizes Scott D. Ferguson's Form 4 filing for Elanco Animal Health Inc (ELAN).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 02 Dec 2021, 17:25.

Change

  • Previous filing in this sequence was filed on 02 Sep 2021.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ELAN transaction

Common Stock

Award

Transaction value
$0
Shares
+7,307
Change %
Price
$0.000000
Shares after
7,307
Date
30 Nov 2021
Ownership
Direct
Footnotes
F1, F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Grant of deferred stock units as an annual equity award to each of the non-employee members of the Issuer's Board of Directors.

Footnote F2

Pursuant to an arrangement between Mr. Ferguson and Sachem Head Capital Management LP ("Sachem Head"), the deferred stock units are held by Mr. Ferguson for the benefit of Sachem Head. Such units are included as directly beneficially owned by Mr. Ferguson, but may also be deemed to be beneficially owned by Sachem Head and Uncas GP LLC, Sachem Head's General Partner, as a result of such arrangements. Each of the Reporting Persons disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .